Based on the GTEx panel of human tissues, we found that wild type SCAF8 had its highest expression in the ovary and uterus, making it an ideal fusion partner to drive high expression in ovarian and endometrial cancers (Fig. 3f). The gene discussed is SCAF8; the disease is endometrial cancer.